`
`BEFORE THE PA TENT TRIAL AND APPEAL BOARD
`
`Regeneron Pharmaceuticals, Inc.,
`
`Petitioner
`
`V.
`
`Novartis Pharma AG, Novartis Technology LLC, and Novartis
`Pharmaceuticals Corporation,
`
`Patent Owners.
`
`U.S. Patent No. 9,220,631 to Sigg et al.
`
`IPR2020-01317
`
`PA TENT OWNER NOV ARTIS TECHNOLOGY LLC'S POWER OF
`ATTORNEY
`
`
`
`U.S. Patent No. 9,220,631
`
`Pursuant to 37 C.F.R. § 42.l0(b), Patent Owner, Novartis Technology LLC,
`
`hereby appoints Goodwin Procter LLP and the following practitioners as its
`
`attorneys to transact all business in the United States Patent & Trademark Office
`
`associated with the above-captioned inter partes review:
`
`Lead Counsel:
`
`Backup Counsel:
`
`Elizabeth J. Holland (Reg. No. 47,657) William G. James (Reg. No. 55,931)
`Goodwin Procter LLP
`Goodwin Procter LLP
`620 Eighth A venue
`1900 N Street, N.W.
`Washington, D.C. 20036
`New York, NY 10018
`Phone: (202) 346-4000
`Phone: (212) 813-8800
`Fax: (202) 346-4444
`Fax: (212) 355-3333
`WJ ames@goodwinlaw.com
`EHolland@goodwinlaw.com
`
`Backup Counsel:
`
`Backup Counsel:
`
`Linnea Cipriano (Reg. No. 67,729)
`Goodwin Procter LLP
`620 Eighth A venue
`New York, NY 10018
`Phone: (212) 813-8800
`Fax: (212) 355-3333
`LCipriano@goodwinlaw.com
`
`Joshua Weinger (Reg. No. 73,198)
`Goodwin Procter LLP
`100 Northern A venue
`Boston, MA 02210
`Phone: (617) 570-1000
`Fax: (617) 523-1231
`JWeinger@goodwinlaw.com
`
`2
`
`
`
`The individual signing below has the authority to execute this document on
`
`U.S. Patent No. 9,220,631
`
`behalf of Patent Owner Novartis Technology LLC.
`
`Date: August 6, 2020
`
`Name: Margaretha Haeussler
`
`Title: Director, Transfer Pricing
`
`3
`
`
`
`CERTIFICATE OF SERVICE
`A copy of this Patent Owner’s Power of Attorney has been served on
`
`
`
`Petitioner’s attorneys of record as follows via electronic mail:
`
`Elizabeth Stotland Weiswasser
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8022
`F: 212-310-8007
`elizabeth.weiswasser@weil.com
`USPTO Reg. No. 55,721
`Anish R. Desai
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8730
`F: 212-310-8007
`anish.desai@weil.com
`USPTO Reg. No. 73,760
`
`Natalie Kennedy
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8730
`F: 212-310-8007
`natalie.kennedy@weil.com
`USPTO Reg. No. 68,511
`Andrew Gesior
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8730
`F: 212-310-8007
`andrew.gesior@weil.com
`
`
`
`U.S. Patent No. 9,220,631
`
`USPTO Reg. No. 76,588
`
`Brian E. Ferguson
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, D.C. 20036
`T : 202-682-7000
`F: 202-857-0940
`brian.ferguson@weil.com
`USPTO Reg. No. 36,801
`
`Christopher M. Pepe
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, D.C. 20036
`T: 202-682-7000
`F: 202-857-0940
`christopher. pepe@weil.com
`USPTO Reg. No. 73 ,851
`
`Regeneron.IPR. Service@weil.com
`
`Attorneys for Regeneron Pharmaceuticals, Inc.
`
`Dated: August 6, 2020
`
`By:
`
`/Elizabeth J Hollandi
`Elizabeth J. Holland (Reg. No. 47,657)
`Lead Counsel for Patent Owners
`Goodwin Procter LLP
`620 Eighth A venue
`New York, NY 10018
`Phone: (212) 813-8800
`Fax: (212) 355-3333
`EHolland@goodwinlaw.com
`
`2
`
`